Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia‐Activated Prodrug Tirapazamine Therapy for Metastatic Tumors
Author:
Affiliation:
1. Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied ChemistryChinese Academy of Sciences Changchun 130022 P. R. China
2. College of ChemistryJilin University Changchun 130012 P. R. China
Funder
Ministry of Science and Technology of the People's Republic of China
Publisher
Wiley
Subject
Mechanical Engineering,Mechanics of Materials,General Materials Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201805955
Reference27 articles.
1. Recent Progress in the Design of Hypoxia-Specific Nano Drug Delivery Systems for Cancer Therapy
2. Targeting hypoxia in cancer therapy
3. Exploiting tumour hypoxia in cancer treatment
4. SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
5. Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy
Cited by 164 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A two-stage exacerbated hypoxia nanoengineering strategy induced amplifying activation of tirapazamine for microwave hyperthermia-chemotherapy of breast cancer;Journal of Colloid and Interface Science;2024-04
2. A new strategy to fight tumor heterogeneity: Integrating metal-defect active centers within NADH oxidase nanozymes;Nano Today;2024-02
3. Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade;Chemical Engineering Journal;2024-02
4. A tumor‐targeting nano‐adjuvant for in situ vaccine based on ultrasound therapy;Aggregate;2024-01-15
5. A light-activatable theranostic combination for ratiometric hypoxia imaging and oxygen-deprived drug activity enhancement;Nature Communications;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3